Log inSign up
AAOIFI No. 21 screening

Is CRIS halal?

Curis, Inc.

Not halal

Curis, Inc. did not pass AAOIFI screening. The failed check is shown below.

Checked: 14 October 2026

Exchange

NASDAQ

Price

0.4071

Day

-19.86%

Market cap

$1.5M

Industry

Biotechnology

Sector

Healthcare

What the company does

Curis is an oncology biotech developing emavusertib (an IRAK4 inhibitor in blood-cancer and lymphoma trials) and earning royalties on Erivedge (basal-cell carcinoma, Genentech). Its money comes from royalties.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $44K ÷ 36-month average market cap $32.82M = 0.1%

    0.1%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $5.07M ÷ 36-month average market cap $32.82M = 15.5%

    15.5%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $316K ÷ annual revenue $9.44M (2025) = 3.4%

    3.4%

    Pass

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $1.50M.

For information (AAOIFI 3/1 note): cash + receivables are 25.4% of total assets (2025-12-31). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500

Superinvestors

SEC 13F, 2026 Q3. Up to 45 days delayed.

Held by 1 superinvestors · Average reported price: $0.12

All superinvestor portfolios

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyCRIS's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →